Michael Davidson to Pandemics
This is a "connection" page, showing publications Michael Davidson has written about Pandemics.
Connection Strength
0.054
-
Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond. Lung Cancer. 2021 06; 156:147-150.
Score: 0.028
-
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis. Curr Atheroscler Rep. 2020 07 25; 22(9):48.
Score: 0.026